Abstract
Alginate overproduction by Pseudomonas aeruginosa, or mucoidy, plays an important role in the pathogenesis of chronic lung infections in cystic fibrosis (CF) patients. Here we report the draft genome sequence of a clinical isolate of mucoid P. aeruginosa strain C7447m from a CF patient with chronic lung infection.
GENOME ANNOUNCEMENT
Overproduction of the capsular polysaccharide alginate by the Gram-negative bacterium Pseudomonas aeruginosa is a hallmark of chronic lung infections in cystic fibrosis (CF) patients. Among its many roles in virulence, alginate protects the bacteria from host defenses (1) and antibiotic chemotherapy (2). Here, we report the genome sequence of a clinical alginate-overproducing, mucoid P. aeruginosa isolate, C7447m. Strain C7447m was originally isolated from a CF patient in 1997 by David P. Speert in Vancouver, British Columbia, Canada.
Genomic DNA extracted by cetyltrimethylammonium bromide (CTAB)-NaCl and phenol-chloroform-isoamyl alcohol was sent to Cofactor Genomics (St. Louis, MO). Paired-end sequencing libraries were generated according to vendor protocols (Illumina, San Diego, CA). The genome sequencing was performed on an Illumina GAIIX. Totals of 11,770,660 raw reads and 1,883,305,600 bp were obtained. The sequence data were generated and assembled using Illumina Pipeline version SCS 2.8.0 based on paired-end tags with OLB 1.8.0. The sequences were then aligned and annotated according to the reference strain PAO1 genome (GenBank accession no. NC_2516.2) by use of the Novocraft novoAlign v 2.07.13 software package. Further analysis of the genome was performed using Samtools version 01.15c for the generation of pileup after sorting and the removal of duplicate reads. The analysis pipeline software was developed by CoFactor Genomics, and all specifics regarding aligner algorithms can be obtained from Novocraft Technologies. In summary, the number of generated base pairs resulted in approximately 224× coverage of the reference PAO1 genome. The number of base pairs saturated at or above 8× is 6,088,140 (97.19%), and the number of base pairs saturated below 8× is 176,264 (2.81%). The genome was annotated and prepared for submission using Ergatis-based workflow with manual correction.
The analysis results of single nucleotide polymorphisms (SNPs) and indels showed that 643 heterozygous mutants (255 indels and 388 SNPs; count ratios of ≥0.4 and ≤0.6) and 25,753 homozygous SNPs (count ratio, >0.6) were found. The count ratio is defined as the number of times the reference base is observed divided by the coverage at this base (counting all matches and mismatches). Only 14 indels, with coverage at the site above 8× and the mutant to wild type ratios at >2, were included in this genome edition. Thirteen of the included indels were distributed in the intergenic region. Among the homozygous SNPs, 22,439 mutations were distributed in 4,516 genes/coding sequence (CDS) (which accounts for 79.47% of the total genes/CDS), and 3,314 mutations were identified in the intergenic region. Most of the mutant genes have multiple SNPs, and 2,846 genes/CDS have 3 or more homozygous SNPs. Despite the mucoid phenotype, the strain C7447m has wild-type algU and mucA. Furthermore, among previously reported alginate production-related genes (3–6), the amino acid sequences of MucC, MucD, AlgL, and KinB each have 1 amino acid change; AlgX has 2 amino acid changes; and AlgI and AlgP have 5 amino acid changes. We also found some SNPs located in the intergenic region before algB, algC, algD, amrZ, clpP2, mucE, mucR, and pilA.
Nucleotide sequence accession number.
The draft genome sequence of C7447m has been deposited in GenBank with the accession number CP006728.
ACKNOWLEDGMENTS
This work was supported by the Cystic Fibrosis Foundation (CFF-YU11G0), the National Aeronautics and Space Administration West Virginia Space Grant Consortium (NASA WVSGC), and NIH P20RR016477 and P20GM103434 to the West Virginia IDeA Network for Biomedical Research Excellence.
Footnotes
Citation Yin Y, Withers TR, Johnson SL, Yu HD. 2013. Draft genome sequence of a mucoid isolate of Pseudomonas aeruginosa strain C7447m from a patient with cystic fibrosis. Genome Announc. 1(5):e00837-13. doi:10.1128/genomeA.00837-13.
REFERENCES
- 1. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. 2005. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J. Immunol. 175:7512–7518 [DOI] [PubMed] [Google Scholar]
- 2. Govan JR, Deretic V. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539–574 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Hay ID, Ur Rehman Z, Ghafoor A, Rehm BHA. 2010. Bacterial biosynthesis of alginates. J. Chem. Technol. Biotechnol. 85:752–759 [Google Scholar]
- 4. Damron FH, Qiu D, Yu HD. 2009. The Pseudomonas aeruginosa sensor kinase KinB negatively controls alginate production through AlgW-dependent MucA proteolysis. J. Bacteriol. 191:2285–2295 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Qiu D, Eisinger VM, Head NE, Pier GB, Yu HD. 2008. ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa. Microbiology 154:2119–2130 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Ryan Withers T, Heath Damron F, Yin Y, Yu HD. 2013. Truncation of type IV pilin induces mucoidy in Pseudomonas aeruginosa strain PAO579. Microbiologyopen 2:459–470 [DOI] [PMC free article] [PubMed] [Google Scholar]